NL8105100A - Indolinonderivaten werkwijze voor het bereiden daarvan alsmede daaruit bereide c.q. vervaardigde farmaceutische preparaten. - Google Patents

Indolinonderivaten werkwijze voor het bereiden daarvan alsmede daaruit bereide c.q. vervaardigde farmaceutische preparaten. Download PDF

Info

Publication number
NL8105100A
NL8105100A NL8105100A NL8105100A NL8105100A NL 8105100 A NL8105100 A NL 8105100A NL 8105100 A NL8105100 A NL 8105100A NL 8105100 A NL8105100 A NL 8105100A NL 8105100 A NL8105100 A NL 8105100A
Authority
NL
Netherlands
Prior art keywords
indolinone
dimethyl
butoxy7
group
theory
Prior art date
Application number
NL8105100A
Other languages
English (en)
Dutch (nl)
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of NL8105100A publication Critical patent/NL8105100A/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NL8105100A 1980-11-12 1981-11-11 Indolinonderivaten werkwijze voor het bereiden daarvan alsmede daaruit bereide c.q. vervaardigde farmaceutische preparaten. NL8105100A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3042632 1980-11-12
DE3042632 1980-11-12

Publications (1)

Publication Number Publication Date
NL8105100A true NL8105100A (nl) 1982-06-01

Family

ID=6116579

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8105100A NL8105100A (nl) 1980-11-12 1981-11-11 Indolinonderivaten werkwijze voor het bereiden daarvan alsmede daaruit bereide c.q. vervaardigde farmaceutische preparaten.

Country Status (29)

Country Link
US (1) US4629733A (enExample)
JP (1) JPS57114569A (enExample)
KR (1) KR880002227B1 (enExample)
AT (1) AT375923B (enExample)
AU (1) AU547929B2 (enExample)
BE (1) BE891103A (enExample)
CA (1) CA1183848A (enExample)
CH (1) CH652120A5 (enExample)
DD (1) DD201889A5 (enExample)
DK (1) DK154138C (enExample)
ES (2) ES8206470A1 (enExample)
FI (1) FI75806C (enExample)
FR (1) FR2493841A1 (enExample)
GB (1) GB2098595B (enExample)
GR (1) GR81330B (enExample)
HU (1) HU183680B (enExample)
IE (1) IE52107B1 (enExample)
IL (1) IL64252A (enExample)
IT (1) IT1171624B (enExample)
LU (1) LU83744A1 (enExample)
NL (1) NL8105100A (enExample)
NO (1) NO156167C (enExample)
NZ (1) NZ198941A (enExample)
PL (1) PL134525B1 (enExample)
PT (1) PT73969B (enExample)
SE (1) SE452156B (enExample)
SU (1) SU1107759A3 (enExample)
YU (1) YU41995B (enExample)
ZA (1) ZA817787B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0089394A1 (en) * 1982-03-23 1983-09-28 Sterling Drug Inc. 1-H-Indole-2,3-dione derivatives and preparation thereof
US5204344A (en) * 1989-08-22 1993-04-20 Merck Frosst Canada, Inc. (Quinolin-2-ylmethoxy)indoles as inhibitors of the biosynthesis of leukotrienes
US5272145A (en) * 1989-08-22 1993-12-21 Merck Frosst Canada, Inc. (Quinolin-2-ylmethoxy)indoles as inhibitors of the biosynthesis of leukotrienes
GB9008605D0 (en) * 1990-04-17 1990-06-13 Smith Kline French Lab Process
US5290798A (en) * 1991-09-30 1994-03-01 Merck Frosst Canada, Inc. (hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis
US5389650A (en) * 1991-09-30 1995-02-14 Merck Frosst Canada, Inc. (Azaarylmethoxy)indoles as inhibitors of leukotriene biosynthesis
US5190968A (en) * 1991-09-30 1993-03-02 Merck Frosst Canada, Inc. (Polycyclic-arylmethoxy) indoles as inhibitors of leukotriene biosynthesis
US5308850A (en) * 1991-09-30 1994-05-03 Merck Frosst Canada, Inc. (Bicyclic-hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis
US5374635A (en) * 1993-03-29 1994-12-20 Merck Frosst Canada, Inc. Furo[3,2-b]pyridines and thieno[3,2-b]pyridines as inhibitors of leukotriene biosynthesis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT330169B (de) * 1971-06-24 1976-06-25 Sandoz Ag Verfahren zur herstellung neuer oxindole und ihrer salze
SU843739A3 (ru) * 1978-02-17 1981-06-30 Карл Томэ Гмбх (Фирма) Способ получени карбостириловыхили ОКСиНдОлОВыХ пРОизВОдНыХ
DE2853314A1 (de) * 1978-12-09 1980-06-26 Thomae Gmbh Dr K Neue carbostyril- und oxindolderivate, ihre herstellung und ihre verwendung als arzneimittel
US4329347A (en) * 1978-02-17 1982-05-11 Boehringer Ingelheim Gmbh Cardiotonic and antithrombotic sulfur-containing derivatives of carbostyril
US4442111A (en) * 1981-07-25 1984-04-10 Dr. Karl Thomae Gesellschaft Mit Beschrankter Haftung Antithrombotic sulfimino and sulfoximino indolinones-2

Also Published As

Publication number Publication date
ES8304081A1 (es) 1983-02-16
IT8149602A1 (it) 1983-04-30
BE891103A (fr) 1982-05-12
DK154138B (da) 1988-10-17
PT73969A (de) 1981-12-01
CA1183848A (en) 1985-03-12
IT8149602A0 (it) 1981-10-30
NO813821L (no) 1982-05-13
PL134525B1 (en) 1985-08-31
GB2098595B (en) 1984-09-05
DK496781A (da) 1982-05-13
HU183680B (en) 1984-05-28
KR830007554A (ko) 1983-10-21
FR2493841B1 (enExample) 1984-03-30
ES507015A0 (es) 1982-08-16
NO156167B (no) 1987-04-27
GR81330B (enExample) 1984-12-11
FI813561L (fi) 1982-05-13
SE452156B (sv) 1987-11-16
IL64252A0 (en) 1982-02-28
AT375923B (de) 1984-09-25
LU83744A1 (de) 1983-04-13
NO156167C (no) 1987-08-05
SE8106704L (sv) 1982-05-13
IL64252A (en) 1985-02-28
SU1107759A3 (ru) 1984-08-07
IE52107B1 (en) 1987-06-24
DD201889A5 (de) 1983-08-17
ES511834A0 (es) 1983-02-16
IT1171624B (it) 1987-06-10
ATA478981A (de) 1984-02-15
IE812640L (en) 1982-05-12
AU547929B2 (en) 1985-11-14
FI75806B (fi) 1988-04-29
JPS57114569A (en) 1982-07-16
US4629733A (en) 1986-12-16
KR880002227B1 (ko) 1988-10-20
PL233774A1 (enExample) 1982-12-20
FI75806C (fi) 1988-08-08
GB2098595A (en) 1982-11-24
PT73969B (de) 1983-11-23
ZA817787B (en) 1983-07-27
YU266681A (en) 1983-10-31
NZ198941A (en) 1984-10-19
FR2493841A1 (fr) 1982-05-14
DK154138C (da) 1989-04-17
AU7739081A (en) 1982-05-20
YU41995B (en) 1988-04-30
CH652120A5 (de) 1985-10-31
ES8206470A1 (es) 1982-08-16

Similar Documents

Publication Publication Date Title
NO860918L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive sulfonylaminoetylforbindelser.
NL8105100A (nl) Indolinonderivaten werkwijze voor het bereiden daarvan alsmede daaruit bereide c.q. vervaardigde farmaceutische preparaten.
Evans et al. Antianaphylactic benzophenones and related compounds
JPS609716B2 (ja) １，２―ベンズインチアゾリン―３―オン類、それらの製造法および医薬としての使用
JPS6025423B2 (ja) １，４−ジヒドロピリジンの製法
PL184860B1 (pl) Chinoksaliny o własnościach leczniczychĆ zwłaszcza antywirusowychĆ sposób ich wytwarzania i środki lecznicze zawierające chinoksaliny jako substancje czynne
FI79704B (fi) Foerfarande foer framstaellning av benzoxazin-2-oner.
CA1146943A (en) 3-methyl-sulphur-containing-methylene-1-lower alkyl-4-quinolones
FI69064C (fi) Foerfarande foer framstaellning av farmakologiskt vaerdefulla karbostyril- och oxindolderivat
JPS5857373A (ja) Ｌ−アスコルビン酸誘導体の製法
Johary et al. Dithiols. Part XVIII. Some water-soluble derivatives containing the sulphonic acid group
NO833157L (no) Sulfamoylbenzofenon-derivater, fremgangsmaate til deres fremstilling, deres anvendelse samt farmasoeytiske preparater paa basis av disse forbindelser
JPS6411015B2 (enExample)
GB2104515A (en) Sulphimines
SU1158041A3 (ru) Способ получени производных сульфимина
Sumpter The structures of the bromodioxindoles of Baeyer and Knop
KR790001577B1 (ko) 이소퀴놀린 유도체의 제조방법
KR830000833B1 (ko) 카보스티릴 및 옥스인돌 유도체의 제조방법
Mustafa 456. Action of Grignard solutions. Part III. Action of Grignard solutions on naphthasultone and its substituted derivatives
CS221324B1 (cs) 5,5-Disubstituované kyseliny 2-amínobarbitnrové
JPS5942670B2 (ja) β−（３−メチル−５−イソオキサゾリル）アクリル酸アミド誘導体及びその製造方法
CS247572B1 (cs) 2-aryl-8-chlor-6-flavonylalifatické kyseliny
JPS61218581A (ja) チオン類
JPH0574588B2 (enExample)
HU183302B (en) Process for producing substituted benzonitril derivatives

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BV The patent application has lapsed